Skip to main content
Top
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Solid Tumor | Research

Oral colonization by gram-negative bacilli in patients with hematologic malignancies and solid tumors compared with healthy controls

Authors: Karla E. Santibañez-Bedolla, Maria J. Orozco-Uriarte, Jose A. Alvarez-Canales, Alejandro E. Macias, Lauro F. Amador-Medina

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Background

Colonization of the oropharynx with gram-negative bacilli (GNB) is considered a negative prognostic factor in immunocompromised individuals. Hemato-oncologic patients represent a high-risk group due to their immunodeficiencies and associated treatments. This study aimed to determine the rates of oral colonization by GNB, associated factors, and clinical outcomes in patients with hematologic malignancies and solid tumors compared with healthy subjects.

Methods

We conducted a comparative study of hemato-oncologic patients and healthy subjects from August to October 2022. Swabs were taken from the oral cavity; specimens with GNB were identified and tested for antimicrobial susceptibility.

Results

We included 206 participants (103 hemato-oncologic patients and 103 healthy subjects). Hemato-oncologic patients had higher rates of oral colonization by GNB (34% vs. 17%, P = 0.007) and GNB resistant to third-generation cephalosporins (11.6% vs. 0%, P < 0.001) compared to healthy subjects. Klebsiella spp. was the predominant genus in both groups. The factor associated with oral colonization by GNB was a Charlson index ≥ 3, while ≥ 3 dental visits per year were a protective factor. Regarding colonization by resistant GNB in oncology patients, antibiotic therapy and a Charlson index ≥ 5 were identified as associated factors, while better physical functionality (ECOG ≤ 2) was associated with less colonization. Hemato-oncologic patients colonized with GNB had more 30-day infectious complications (30.5% vs. 2.9%, P = 0.0001) than non-colonized patients.

Conclusion

Oral colonization by GNB and resistant GNB are prevalent in cancer patients, especially those with higher scores on the severity scales. Infectious complications occurred more frequently in colonized patients. There is a knowledge gap about dental hygiene practices in hemato-oncologic patients colonized by GNB. Our results suggest that patients’ hygienic-dietary habits, especially frequent dental visits, are a protective factor against colonization.
Appendix
Available only for authorised users
Literature
2.
go back to reference Lam OL, McGrath C, Li LS, Samaranayake LP. Effectiveness of oral hygiene interventions against oral and oropharyngeal reservoirs of aerobic and facultatively anaerobic gram-negative bacilli. Am J Infect Control. 2012;40:175–82.CrossRefPubMed Lam OL, McGrath C, Li LS, Samaranayake LP. Effectiveness of oral hygiene interventions against oral and oropharyngeal reservoirs of aerobic and facultatively anaerobic gram-negative bacilli. Am J Infect Control. 2012;40:175–82.CrossRefPubMed
3.
go back to reference Espíndola LCP, Picão RC, Mançano SMCN, Martins do Souto R, Colombo APV. Prevalence and antimicrobial susceptibility of Gram-negative bacilli in subgingival biofilm associated with periodontal diseases. J Periodontol. 2022;93:69–79.CrossRefPubMed Espíndola LCP, Picão RC, Mançano SMCN, Martins do Souto R, Colombo APV. Prevalence and antimicrobial susceptibility of Gram-negative bacilli in subgingival biofilm associated with periodontal diseases. J Periodontol. 2022;93:69–79.CrossRefPubMed
4.
go back to reference Yoshizawa K, Moroi A, Iguchi R, Yokomichi H, Ogihara S, Watanabe K, et al. Association between the point-rating system used for oral health and the prevalence of Gram-negative bacilli in hematological inpatients: a retrospective cohort study. Medicine. 2021;100:e26111.CrossRefPubMedPubMedCentral Yoshizawa K, Moroi A, Iguchi R, Yokomichi H, Ogihara S, Watanabe K, et al. Association between the point-rating system used for oral health and the prevalence of Gram-negative bacilli in hematological inpatients: a retrospective cohort study. Medicine. 2021;100:e26111.CrossRefPubMedPubMedCentral
5.
go back to reference Hess AS, Kleinberg M, Sorkin JD, Netzer G, Johnson JK, Shardell M, et al. Prior colonization is associated with increased risk of antibiotic-resistant Gram-negative bacteremia in cancer patients. Diagn Microbiol Infect Dis. 2014;79:73.CrossRefPubMedPubMedCentral Hess AS, Kleinberg M, Sorkin JD, Netzer G, Johnson JK, Shardell M, et al. Prior colonization is associated with increased risk of antibiotic-resistant Gram-negative bacteremia in cancer patients. Diagn Microbiol Infect Dis. 2014;79:73.CrossRefPubMedPubMedCentral
6.
go back to reference Zecha JAEM, Raber-Durlacher JE, Laheij AMGA, Westermann AM, Epstein JB, de Lange J, et al. The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy. Support Care Cancer. 2019;27:3667–79.CrossRefPubMedPubMedCentral Zecha JAEM, Raber-Durlacher JE, Laheij AMGA, Westermann AM, Epstein JB, de Lange J, et al. The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy. Support Care Cancer. 2019;27:3667–79.CrossRefPubMedPubMedCentral
7.
go back to reference Pagano L, Caira M, Trecarichi E, Spanu T, Di Blasi R, Sica S, et al. Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies. Emerg Infect Dis. 2014;20:1235–6.CrossRefPubMedPubMedCentral Pagano L, Caira M, Trecarichi E, Spanu T, Di Blasi R, Sica S, et al. Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies. Emerg Infect Dis. 2014;20:1235–6.CrossRefPubMedPubMedCentral
8.
go back to reference Tseng WP, Chen YC, Chen SY, Chen SY, Chang SC. Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection. Antimicrob Resist Infect Control. 2018;31:7:93.CrossRef Tseng WP, Chen YC, Chen SY, Chen SY, Chang SC. Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection. Antimicrob Resist Infect Control. 2018;31:7:93.CrossRef
9.
go back to reference Cattaneo C, di Blasi R, Skert C, Candoni A, Martino B, di Renzo N, et al. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria. Ann Hematol. 2018;97:1717–26.CrossRefPubMed Cattaneo C, di Blasi R, Skert C, Candoni A, Martino B, di Renzo N, et al. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria. Ann Hematol. 2018;97:1717–26.CrossRefPubMed
10.
go back to reference Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):31–4.CrossRef Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):31–4.CrossRef
12.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRefPubMed Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–81.CrossRefPubMed
13.
go back to reference Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2008;Suppl 1:90–103.CrossRef Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2008;Suppl 1:90–103.CrossRef
14.
go back to reference Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sánchez-Ortega I, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66:657–63.CrossRefPubMed Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sánchez-Ortega I, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66:657–63.CrossRefPubMed
15.
go back to reference Sadowska-Klasa A, Piekarska A, Prejzner W, Bieniaszewska M, Hellmann A. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation. Ann Hematol. 2018;97:509–17.CrossRefPubMed Sadowska-Klasa A, Piekarska A, Prejzner W, Bieniaszewska M, Hellmann A. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation. Ann Hematol. 2018;97:509–17.CrossRefPubMed
16.
go back to reference Guentzel MN, Escherichia. Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus. In: Baron S, editor. Medical Microbiology. 4th ed. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Guentzel MN, Escherichia. Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus. In: Baron S, editor. Medical Microbiology. 4th ed. Galveston (TX): University of Texas Medical Branch at Galveston; 1996.
17.
18.
go back to reference Rodrigues C, Hauser K, Cahill N, Ligowska-Marzęta M, Centorotola G, Cornacchia A, et al. High prevalence of Klebsiella pneumoniae in european Food Products: a multicentric study comparing culture and molecular detection methods. Microbiol Spectr. 2022;10(1):e0237621.CrossRefPubMed Rodrigues C, Hauser K, Cahill N, Ligowska-Marzęta M, Centorotola G, Cornacchia A, et al. High prevalence of Klebsiella pneumoniae in european Food Products: a multicentric study comparing culture and molecular detection methods. Microbiol Spectr. 2022;10(1):e0237621.CrossRefPubMed
19.
go back to reference Guo Y, Zhou H, Qin L, Pang Z, Qin T, Ren H, et al. Frequency, Antimicrobial Resistance and genetic diversity of Klebsiella pneumoniae in Food samples. PLoS ONE. 2016;11(4):e0153561.CrossRefPubMedPubMedCentral Guo Y, Zhou H, Qin L, Pang Z, Qin T, Ren H, et al. Frequency, Antimicrobial Resistance and genetic diversity of Klebsiella pneumoniae in Food samples. PLoS ONE. 2016;11(4):e0153561.CrossRefPubMedPubMedCentral
20.
go back to reference Korona-Glowniak I, Grywalska E, Chudzik B, Bojarska-Junak A, Malm A, Rolinski J. Upper respiratory tract colonization by gram-negative rods in patients with chronic lymphocytic leukemia: analysis of risk factors. ScientificWorldJournal. 2012; 2012:617218. Korona-Glowniak I, Grywalska E, Chudzik B, Bojarska-Junak A, Malm A, Rolinski J. Upper respiratory tract colonization by gram-negative rods in patients with chronic lymphocytic leukemia: analysis of risk factors. ScientificWorldJournal. 2012; 2012:617218.
21.
go back to reference Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med. 1969;281:1137–40.CrossRefPubMed Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med. 1969;281:1137–40.CrossRefPubMed
22.
go back to reference Mobbs KJ, van Saene HKF, Sunderland D, Davies PDO. Oropharyngeal Gram-negative Bacillary Carriage: a Survey of 120 healthy individuals. Chest. 1999;115:1570–5.CrossRefPubMed Mobbs KJ, van Saene HKF, Sunderland D, Davies PDO. Oropharyngeal Gram-negative Bacillary Carriage: a Survey of 120 healthy individuals. Chest. 1999;115:1570–5.CrossRefPubMed
23.
go back to reference Holmes CL, Anderson MT, Mobley HLT, Bachman MA. Pathogenesis of Gram-Negative bacteremia. Clin Microbiol Rev. 2021;10:34: e00234–20. Holmes CL, Anderson MT, Mobley HLT, Bachman MA. Pathogenesis of Gram-Negative bacteremia. Clin Microbiol Rev. 2021;10:34: e00234–20.
24.
go back to reference Yamagata K, Onizawa K, Yanagawa T, Hasegawa Y, Kojima H, Nagasawa T, et al. A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006;38(3):237–42.CrossRefPubMed Yamagata K, Onizawa K, Yanagawa T, Hasegawa Y, Kojima H, Nagasawa T, et al. A prospective study to evaluate a new dental management protocol before hematopoietic stem cell transplantation. Bone Marrow Transplant. 2006;38(3):237–42.CrossRefPubMed
25.
go back to reference Yamada SI, Soutome S, Hasegawa T, Tojyo I, Nakahara H, Kawakami M, et al. A multicenter retrospective investigation on the efficacy of perioperative oral management in cancer patients. Medicine. 2020;99:e19129.CrossRefPubMedPubMedCentral Yamada SI, Soutome S, Hasegawa T, Tojyo I, Nakahara H, Kawakami M, et al. A multicenter retrospective investigation on the efficacy of perioperative oral management in cancer patients. Medicine. 2020;99:e19129.CrossRefPubMedPubMedCentral
26.
go back to reference Choi SE, Kim HS. Sodium bicarbonate solution versus chlorhexidine mouthwash in oral care of acute leukemia patients undergoing induction chemotherapy: a randomized controlled trial. Asian Nurs Res (Korean Soc Nurs Sci). 2012;6:60–6.PubMed Choi SE, Kim HS. Sodium bicarbonate solution versus chlorhexidine mouthwash in oral care of acute leukemia patients undergoing induction chemotherapy: a randomized controlled trial. Asian Nurs Res (Korean Soc Nurs Sci). 2012;6:60–6.PubMed
27.
go back to reference Amador-Medina LF, Alvarez JA, Macias AE, Muñoz JM, Mosqueda JL, Arreguin V, et al. Does chlorhexidine mouthwash reduce the rate of oral colonization by gram-negative bacteria in patients with chemotherapy? A placebo-controlled trial. Am J Infect Control. 2019;47:591–4.CrossRefPubMed Amador-Medina LF, Alvarez JA, Macias AE, Muñoz JM, Mosqueda JL, Arreguin V, et al. Does chlorhexidine mouthwash reduce the rate of oral colonization by gram-negative bacteria in patients with chemotherapy? A placebo-controlled trial. Am J Infect Control. 2019;47:591–4.CrossRefPubMed
28.
go back to reference Dimitriou V, Biehl LM, Hamprecht A, Vogel W, Dörfel D, Peter S, et al. Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, phase II trial (CLEAR). J Antimicrob Chemother. 2019;74:2065–74.CrossRefPubMed Dimitriou V, Biehl LM, Hamprecht A, Vogel W, Dörfel D, Peter S, et al. Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, phase II trial (CLEAR). J Antimicrob Chemother. 2019;74:2065–74.CrossRefPubMed
29.
go back to reference Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, et al. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother. 2010;65:333–41.CrossRefPubMed Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, et al. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. J Antimicrob Chemother. 2010;65:333–41.CrossRefPubMed
30.
go back to reference Patriarca F, Cigana C, Massimo D, Lazzarotto D, Geromin A, Isola M, et al. Risk factors and outcomes of infections by Multidrug-Resistant Gram-Negative Bacteria in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:333–9.CrossRefPubMed Patriarca F, Cigana C, Massimo D, Lazzarotto D, Geromin A, Isola M, et al. Risk factors and outcomes of infections by Multidrug-Resistant Gram-Negative Bacteria in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:333–9.CrossRefPubMed
Metadata
Title
Oral colonization by gram-negative bacilli in patients with hematologic malignancies and solid tumors compared with healthy controls
Authors
Karla E. Santibañez-Bedolla
Maria J. Orozco-Uriarte
Jose A. Alvarez-Canales
Alejandro E. Macias
Lauro F. Amador-Medina
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-03172-y

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue